Global Bulimia Nervosa Market At A CAGR Of 6% During Forecast Period 2022-2030

Pune, India, June 2022 /MRFR Press Release/- Market Research Future published a half-cooked research report on Global bulimia nervosa market.

Market Highlights

Bulimia nervosa is an eating disorder associated with eating a large amount of food in short time. People suffering from bulimia nervosa is increasing continuously around the globe. As eating disorders are triggered by negative energy balance accompanied by weight loss. Factors like stress, fat-shaming, nutrition education, pressure to be thin and many more are responsible causing this disorder. Diseases like diabetes and many other cardiovascular diseases are also responsible for increasing the market on bulimia nervosa. High cost of treatment is the major restraining factor for the growth of the market. Global bulimia nervosa market is expected to reach USD 735.8 Million by 2030 at a CAGR of 6% during forecasted period 2022-2030.

On regional basis, North America has the leading bulimia nervosa market due to increasing prevalence of this disorder in North America. 6.2 million people are suffering with this bulimia nervosa in North America majority of them are young adults. Beside this unmet need of medication and technological advances is the other factor for growth of this market in North America. North America is followed by Europe in bulimia nervosa market. Increasing number of diabetic population, patents suffering from other cardiovascular diseases, technological advances and well developed healthcare sector has led to grow this market in Europe. Asia Pacific is the fastest growing market due to a huge population base and increasing prevalence of diabetes and other bulimia nervosa causing disease. Middle East and Africa has the least market for bulimia nervosa.

Segmentation:
Global bulimia nervosa market is segmented into type of treatment into psychotherapy, drug therapy and other. Psychotherapy is further sub segmented into maudsley family therapy and other. Drug therapy is further sub segmented into antidepressants and other.

Figure 1- Global bulimia nervosa market share, by region

Competitive Analysis
The major key player for the global bulimia nervosa market are Siemens Healthcare GmbH (Germany), Philips Healthcare (U.S), Abbott (U.S), Johnson & Johnson Services, Inc.(U.S), Stryker (U.S), General Electric Company (U.K), Covidien ltd (Ireland), Penumbra, Inc. (U.S).
Due to increasing prevalence of bulimia nervosa across the globe many of the companies are in the race to introduce better treatment for bulimia nervosa. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of  Bulimia Nervosa Market Research Report